ITGAX and infection: Figure 3A shows the gating strategy used to characterize these cells. As can be seen in Figure 3B, at 96 hours and 2 weeks after infection both agonists increased while the antagonist reduced the number of CD11c+ cells expressing intracellular IDO and AhR.